HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,572 | -33.7% | 292,100 | -28.8% | 0.02% | -23.8% |
| Q2 2023 | $14,442 | -5.0% | 410,400 | -11.9% | 0.02% | +5.0% |
| Q1 2023 | $15,208 | -19.5% | 465,800 | +35.9% | 0.02% | -23.1% |
| Q4 2022 | $18,883 | -99.9% | 342,700 | +5.4% | 0.03% | +30.0% |
| Q3 2022 | $14,394,000 | +1.1% | 325,000 | +11.4% | 0.02% | +17.6% |
| Q2 2022 | $14,231,000 | +105.3% | 291,800 | +104.8% | 0.02% | +112.5% |
| Q1 2022 | $6,933,000 | +20.6% | 142,500 | +5.7% | 0.01% | +14.3% |
| Q4 2021 | $5,748,000 | +280.7% | 134,800 | +242.1% | 0.01% | +250.0% |
| Q3 2021 | $1,510,000 | +353.5% | 39,400 | +233.9% | 0.00% | – |
| Q2 2021 | $333,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $478,337,000,000 | 76.20% |
| venBio Partners LLC | 2,740,411 | $116,851,000 | 21.05% |
| Vivo Capital, LLC | 4,884,341 | $208,268,000 | 12.56% |
| HealthInvest Partners AB | 195,000 | $8,315,000 | 11.72% |
| Nan Fung Group Holdings Ltd | 768,708 | $32,778,000 | 9.70% |
| Aisling Capital Management LP | 355,415 | $15,155,000 | 5.35% |
| ASHFORD CAPITAL MANAGEMENT INC | 694,783 | $29,626,000 | 2.95% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 236,000 | $10,063,000 | 2.24% |
| Newlight Partners LP | 900,824 | $38,411,000 | 2.12% |
| MPM BioImpact LLC | 142,437 | $6,074,000 | 1.11% |